Magnolol Suppresses Osteosarcoma Progression<i>via</i>Apoptosis Induction and EGFR/AKT Pathway Inactivation in a U-2 OS Xenograft Model

Magnolol exerts potent anti-osteosarcoma effects by inducing apoptosis and inhibiting the EGFR/AKT signaling pathway, supporting its potential as a safe adjunctive therapy.

Authors

Institutions

Publication Details

Journal
Anticancer Research
Published
2025-06-27
DOI
https://doi.org/10.21873/anticanres.17662
Primary Topic
Magnolia and Illicium research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Magnolol Suppresses Osteosarcoma ProgressionviaApoptosis Induction and EGFR/AKT Pathway Inactivation in a U-2 OS Xenograft Model

Bang.an Peng, Fei‐Ting Hsu, Chia‐Jung Tsai, Hsiao-Chia Wang et al.
Anticancer Research
Magnolia and Illicium research
article

Magnolol Suppresses Osteosarcoma ProgressionviaApoptosis Induction and EGFR/AKT Pathway Inactivation in a U-2 OS Xenograft Model

Bang.an Peng, Fei‐Ting Hsu, Chia‐Jung Tsai, Hsiao-Chia Wang, Chi-Huan Li, Mao-Chi Weng, JIANN-HWA CHEN, Chunchun Han, Tsai-Lan Liao
article en

Abstract

Magnolol exerts potent anti-osteosarcoma effects by inducing apoptosis and inhibiting the EGFR/AKT signaling pathway, supporting its potential as a safe adjunctive therapy.

Anticancer ResearchVol. 45(7)
Fu Jen Catholic University (TW), Cathay General Hospital (TW)
Zero hunger
Openalex Percentile: Top 81%
Magnolia and Illicium research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.